Dr Reddy’s launches India’s first immuno-oncology drug to treat rare form of head and neck cancer
Dr Reddy’s Laboratories on November 28 launched India's first immuno-oncology drug, Toripalimab, to treat a rare form of cancer. The drug is approved for the treatment of nasopharyngeal carcinoma, a rare type of head and neck cancer. The Hyderabad- …